tiprankstipranks
Astria Therapeutics (ATXS)
NASDAQ:ATXS
Holding ATXS?
Track your performance easily

Astria Therapeutics (ATXS) Financial Statements

1,040 Followers

Astria Therapeutics Financial Overview

Astria Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.093; its P/E ratio is -4.78; Astria Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -24.53M$ -24.17M$ -19.93M$ -20.24M$ -12.57M
EBITDA$ -24.53M$ -24.17M$ -19.93M$ -20.24M$ -12.57M
Net Income Common Stockholders$ -24.53M$ -24.17M$ -19.93M$ -17.73M$ -12.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 344.28M$ 354.70M$ 369.91M$ 188.81M$ 202.96M
Total Assets$ 361.64M$ 367.99M$ 378.81M$ 193.86M$ 207.05M
Total Debt$ 5.64M$ 5.79M$ 168.00K$ 488.00K$ 643.00K
Net Debt$ -338.64M$ -348.91M$ -369.74M$ -188.32M$ -202.31M
Total Liabilities$ 19.98M$ 20.91M$ 11.07M$ 9.38M$ 6.65M
Stockholders Equity$ 341.65M$ 347.08M$ 367.74M$ 184.48M$ 200.40M
Cash Flow-
Free Cash Flow$ -27.98M$ -17.10M$ -19.09M$ -14.26M$ -10.70M
Operating Cash Flow$ -27.96M$ -16.79M$ -19.09M$ -14.26M$ -10.70M
Investing Cash Flow$ 6.19M$ -68.10M$ -126.23M$ -4.00K$ -57.92M
Financing Cash Flow$ 15.30M$ 94.00K$ 141.81M$ 110.00K$ 273.00K
Currency in USD

Astria Therapeutics Earnings and Revenue History

Astria Therapeutics Debt to Assets

Astria Therapeutics Cash Flow

Astria Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis